Top in GI: The value of colonoscopy; guidance on anti-obesity medications
Click Here to Manage Email Alerts
In response to controversial study data on the efficacy of colonoscopies, Nadeem Baig, MD, stressed that they are effective at saving lives when performed.
“The NordICC trial data show that when people did get colonoscopy, it reduced the risk for [colorectal cancer (CRC)] by 31% and cut the risk for dying from CRC by 50%,” Baig, who is the vice president and chief medical officer of Allied Digestive Health in New Jersey, said.
In his editorial, Baig said the study underscores “the critical importance of CRC screening.” It was the top story in gastroenterology last week.
Another top story covered new guidance from the American Gastroenterological Association (AGA) on anti-obesity medications, which the organization ranked in order of effectiveness.
Read these and more top stories in gastroenterology below:
NordICC trial doesn’t change the value of colonoscopy
Despite some sensational headlines following the publication of NordICC trial data in The New England Journal of Medicine, it’s important to understand that this study does not change the value of colonoscopy. Read more.
AGA releases first guideline ranking most effective anti-obesity medications
The AGA has released its first guideline endorsing the use of four medications for obesity management, when paired with lifestyle interventions, for patients who have failed to lose weight with diet and exercise alone. Read more.
Shift in hepatitis A outbreaks ‘unprecedented’ in HAV vaccine era, CDC reports
Recent and ongoing outbreaks associated with person-to-person transmission have marked a shift in hepatitis A virus epidemiology in the United States, according to data published in Morbidity and Mortality Weekly Report. Read more.
Environmental pollutant exposure linked to higher IBS incidence in California residents
Particulate matter and toxic release exposure correlated with a higher incidence of irritable bowel syndrome among a subset of California residents, according to data published in Clinical Gastroenterology and Hepatology. Read more.
GI OnDemand partners with Mindset Health, Trellus Health to expand patient offerings
Virtual integrated care platform, GI OnDemand, has partnered with Mindset Health, a hypnotherapy mobile app, just days after announcing its partnership with Trellus Health, an inflammatory bowel disease management solution. Read more.